New Automated Chemistry Analyzer Presented at IBMS 2015
By LabMedica International staff writers Posted on 11 Oct 2015 |
A new clinical chemistry analyzer provides an automated bench-top platform with an integrated chemistry system supported by a broad menu of ready-to-use, bar coded reagents.
EKF Diagnostics (Cardiff, UK) announced the UK launch of its “Altair 240” clinical chemistry analyzer at the Institute of Biomedical Science Congress 2015 (IBMS, September 28-30, 2015; Birmingham, UK). Also highlighted was the latest additions to its range of Stanbio liquid-stable, LiquiColor and Liqui-UV reagents, including an assay for Procalcitonin.
Altair 240 fulfills a need for an automated, cost-effective bench-top platform supported by the reliable Stanbio Chemistry liquid reagent menu for routine and special chemistries. Altair 240 also provides the flexibility to configure open-channel applications for many esoteric assays. Built on 54 years of expertise, the system with LIS bi-directional connectivity is easy-to-use, as either a main or back-up analyzer, and is capable of performing up to 480 tests/hour (double-arm functionality yields up to 480 tests/hour).
Also presented at IBMS 2015 was the Stanbio Chemistry - Procalcitonin (PCT) LiquiColor Assay, a new rapid test enabling the quantitative determination of PCT in serum samples, EDTA, or lithium heparin plasma samples by latex-enhanced immunoturbidimetric methodology. PCT is a marker for bacterial infection and sepsis and has been recognized as an important adjunct marker in the diagnosis of sepsis. The test provides a precise result that correlates well with established methodology, within 10 minutes and requires only 20 µL of sample. The reagents may be used on almost any liquid-based chemistry analyzer with open-channel capability. Reagent kit, calibrator, and control sets are available separately.
Other products showcased at EKF’s IBMS booth included: B-Hydroxybutyrate (B-HB) LiquiColor Assay for ketosis testing; Glycated Serum Protein (GSP) LiquiColor Assay – a 2-3 week indicator of average blood glucose; Quo-Lab and Quo-Test devices for HbA1c measurement; and Hemo Control hemoglobin analyzer.
Related Links:
EKF Diagnostics
EKF Diagnostics (Cardiff, UK) announced the UK launch of its “Altair 240” clinical chemistry analyzer at the Institute of Biomedical Science Congress 2015 (IBMS, September 28-30, 2015; Birmingham, UK). Also highlighted was the latest additions to its range of Stanbio liquid-stable, LiquiColor and Liqui-UV reagents, including an assay for Procalcitonin.
Altair 240 fulfills a need for an automated, cost-effective bench-top platform supported by the reliable Stanbio Chemistry liquid reagent menu for routine and special chemistries. Altair 240 also provides the flexibility to configure open-channel applications for many esoteric assays. Built on 54 years of expertise, the system with LIS bi-directional connectivity is easy-to-use, as either a main or back-up analyzer, and is capable of performing up to 480 tests/hour (double-arm functionality yields up to 480 tests/hour).
Also presented at IBMS 2015 was the Stanbio Chemistry - Procalcitonin (PCT) LiquiColor Assay, a new rapid test enabling the quantitative determination of PCT in serum samples, EDTA, or lithium heparin plasma samples by latex-enhanced immunoturbidimetric methodology. PCT is a marker for bacterial infection and sepsis and has been recognized as an important adjunct marker in the diagnosis of sepsis. The test provides a precise result that correlates well with established methodology, within 10 minutes and requires only 20 µL of sample. The reagents may be used on almost any liquid-based chemistry analyzer with open-channel capability. Reagent kit, calibrator, and control sets are available separately.
Other products showcased at EKF’s IBMS booth included: B-Hydroxybutyrate (B-HB) LiquiColor Assay for ketosis testing; Glycated Serum Protein (GSP) LiquiColor Assay – a 2-3 week indicator of average blood glucose; Quo-Lab and Quo-Test devices for HbA1c measurement; and Hemo Control hemoglobin analyzer.
Related Links:
EKF Diagnostics
Read the full article by registering today, it's FREE!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Clinical Chem. News
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
- New Blood Testing Method Detects Potent Opioids in Under Three Minutes
- Wireless Hepatitis B Test Kit Completes Screening and Data Collection in One Step
- Pain-Free, Low-Cost, Sensitive, Radiation-Free Device Detects Breast Cancer in Urine
- Spit Test Detects Breast Cancer in Five Seconds
- Electrochemical Sensors with Next-Generation Coating Advances Precision Diagnostics at POC
- First-Of-Its-Kind Handheld Device Accurately Detects Fentanyl in Urine within Seconds
- New Fluorescent Sensor Array Lights up Alzheimer’s-Related Proteins for Earlier Detection
- Automated Mass Spectrometry-Based Clinical Analyzer Could Transform Lab Testing
- Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses
- Non-Invasive Sensor Monitors Changes in Saliva Compositions to Rapidly Diagnose Diabetes
- Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia
- Urine Test for Monitoring Changes in Kidney Health Markers Can Predict New-Onset Heart Failure
- AACC Releases Comprehensive Diabetes Testing Guidelines